Observational Study of the CADScor System for Coronary Artery Disease

This study is looking at how well a device called the CADScor System performs in detecting Coronary Artery Disease (CAD), a condition where blood vessels supplying the heart become narrowed. The study will compare the results from the Acoustic Detection of Blood Flow using the CADScor System to those from a Coronary CTA (Computed Tomography Angiography), a special X-ray test. You may be able to join if you are 30 years or older, have symptoms that suggest stable angina (chest pain or discomfort due to CAD), and have no prior history of heart attack or procedures like stents or bypass surgery. The main goal is to see how well the CADScor System works over one year. The study is currently unclear on its recruitment status.

Study design
This is an observational study planning to enroll 200 participants. It is designed to compare a new diagnostic test to a standard one.
What's involved
You will have the acoustic device scoring performed before a Coronary CTA. No treatment decisions will be based on the acoustic device score.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from enrollment through 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06655779

Performance of the Acoustic Based CADScor System in Coronary Artery Disease

Not Yet Recruiting
Not specifiedAges 30+Observational
INTEGRIS Baptist Medical Center
~200 participants
Updated 2024-10-23 on ClinicalTrials.gov
What's tested:Acoustic Detection of Blood Flow

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Objective
Measured over From enrollment through 1 year
Coronary Artery Disease
Angina (stable)
1 sites across 1 states
Oklahoma1
  • Jon P Blaschke, MD · PRINCIPAL_INVESTIGATOR · INTEGRIS Baptist Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Primary ObjectiveFrom enrollment through 1 year

    To determine that the sensitivity of the CAD score in low to intermediate-risk patients referred for coronary CTA in non-inferior to the device specified sensitivity at 89%.